Alamance Regional Medical Ctr. Cancer Ctr. — Burlington, North Carolina

Alamance Regional Medical Ctr. Cancer Ctr. is a clinical research site located in Burlington, North Carolina, United States 27215.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Alamance Regional Medical Ctr. Cancer Ctr. has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alamance Regional Medical Ctr. Cancer Ctr.?

Alamance Regional Medical Ctr. Cancer Ctr. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alamance Regional Medical Ctr. Cancer Ctr. conducted?

Alamance Regional Medical Ctr. Cancer Ctr. has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Is Alamance Regional Medical Ctr. Cancer Ctr. accredited by Crixeo Health?

Alamance Regional Medical Ctr. Cancer Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alamance Regional Medical Ctr. Cancer Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.